1-(2-溴乙氧基)-2-溴苯 | 18800-28-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-(2-溴乙氧基)-2-溴苯
• 中文别名: 1-溴-2-(2-溴乙氧基)苯
• 英文名称: 1-bromo-2-(2-bromoethoxy)benzene
• CAS: 18800-28-7
• 化学式: C₈H₈Br₂O
• mdl: MFCD00634301
• 分子量: 279.959
• InChiKey: LOVVQTBEUIBASP-UHFFFAOYSA-N

物化性质

• 熔点：
  35-36 °C
• 沸点：
  160-162 °C (16 mmHg)
• 密度：
  1.757±0.06 g/cm3(Predicted)
• 稳定性/保质期：

  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2909309090
• 储存条件：
  存放于阴凉干燥处。

SDS

Name:	1-(2-Bromoethoxy)-2-bromobenzene 95% Material Safety Data Sheet
Synonym:
CAS:	18800-28-7

Section 1 - Chemical Product MSDS Name:1-(2-Bromoethoxy)-2-bromobenzene 95% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
18800-28-7	1-(2-Bromoethoxy)-2-bromobenzene	95%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 18800-28-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: white
Odor: stench
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 160 - 162 deg C @16mmHg
Freezing/Melting Point: 35 - 36 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >160 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H8Br2O
Molecular Weight: 279.96

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 18800-28-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(2-Bromoethoxy)-2-bromobenzene - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AVIATION REGULATED SOLID, N.O.S.*
Hazard Class: 9
UN Number: 3335
Packing Group:
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 18800-28-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 18800-28-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 18800-28-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-(2-溴乙氧基)-2-溴苯 在 乙醚 、 sodium 作用下， 生成 2,3-二氢苯并呋喃
  参考文献：
  名称：

  Stoermer; Goehl, Chemische Berichte, 1903, vol. 36, p. 2875 Anm. 2

  摘要：

  DOI：
• 作为产物：
  描述：

  2-溴苯酚 、 1,2-二溴乙烷 在 caesium carbonate 作用下， 以 乙腈 为溶剂， 反应 11.0h， 以88%的产率得到1-(2-溴乙氧基)-2-溴苯
  参考文献：
  名称：

  通过钯催化的CH活化方便地获得2-苯并ze庚因：鉴定独特的Hsp90抑制剂支架

  摘要：

  生物活性的2-苯并ze庚因是通过通用的钯催化的CH活化方法以原子经济和分步经济的方式获得的。CH芳基化反应需要低的催化剂负载量和适度的碱，这反映在宽范围和高官能团耐受性上。苯并三唑并二氮杂吡啶酮被鉴定为新的抑制热激蛋白90（Hsp90）的先导化合物，在抗癌应用中具有相当大的潜力。

  DOI：

  10.1002/chem.201804244

文献信息

• Novel Bicyclic Pyridinones
  申请人：Pettersson Martin Youngjin

  公开号：US20120252758A1

  公开（公告）日：2012-10-04

  Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

  所述化合物及其药用可接受的盐被披露，其中所述化合物具有如本文所定义的Formula I的结构。相应的药物组合物、治疗方法、合成方法和中间体也被披露。
• Synthesis, antimicrobial evaluation, and in silico studies of quinoline—1H-1,2,3-triazole molecular hybrids
  作者：Paul Awolade、Nosipho Cele、Nagaraju Kerru、Parvesh Singh

  DOI：10.1007/s11030-020-10112-3

  日期：2021.11

  copper(I)-catalyzed azide-alkyne [3 + 2] dipolar cycloaddition reaction (CuAAC). Antimicrobial evaluation identified compound 16 as the most active hybrid in the library with a broad-spectrum antibacterial activity at an MIC80 value of 75.39 μM against methicillin-resistant S. aureus, E. coli, A. baumannii, and multidrug-resistant K. pneumoniae. The compound also showed interesting antifungal profile against C.

  摘要 抗菌素耐药性已成为对全球公共卫生的重大威胁，因此迫切需要具有改善治疗效果的新药。在这方面，分子杂交被认为是提供多靶点候选药物的可行策略。在此，我们报告了通过铜 (I) 催化的叠氮化物-炔烃 [3 + 2] 偶极环加成反应 (CuAAC) 合成的喹啉—1 H -1,2,3-三唑分子杂化物库。抗菌评估确定化合物16是文库中最活跃的杂合体，对耐甲氧西林金黄色葡萄球菌、大肠杆菌、鲍曼不动杆菌的 MIC 80值为 75.39 μM，具有广谱抗菌活性。和多重耐药肺炎克雷伯菌。该化合物还显示出有趣的抗白色念珠菌和新型念珠菌的抗真菌特性，MIC 80值分别为 37.69 和 2.36 μM，优于氟康唑。体外毒性分析显示对人红细胞 (hRBC) 无溶血活性，但对人胚胎肾细胞 (HEK293) 有部分细胞毒性。此外，计算机研究预测了优异的药物样特性以及三唑环在稳定与靶蛋白络合方面的重要性。总体而言，这些
• Oxidative cyclotrimerization of unsaturated compounds with DDQ and triflic acid: An efficient synthetic route to triply-fused benzene rings
  作者：Hee Yeon Cho、Lawrence T. Scott

  DOI：10.1016/j.tetlet.2014.12.141

  日期：2015.6

  Intermolecular oxidative cyclotrimerization reactions of alkenes and aromatic compounds with DDQ and trifluoromethanesulfonic acid are described. Scholl-type oxidation reactions involving alkenes have not previously been demonstrated. Moreover, the DDQ/acid system has never been used for intermolecular oxidative cyclization reactions. This convenient, metal-free reagent system (DDQ/TfOH) is advantageous

  描述了烯烃和芳族化合物与DDQ和三氟甲磺酸的分子间氧化环三聚反应。以前尚未证明涉及烯烃的肖尔型氧化反应。此外，DDQ /酸体系从未用于分子间氧化环化反应。对于金属基Scholl型氧化剂而言，这种方便的无金属试剂系统（DDQ / TfOH）具有优势，因为它消除了作为竞争性副反应的芳香族化合物卤化的可能性。
• SYNTHESIS OF α-AMINO ACIDS FROM ETHYL CYANOACETATE
  作者：Paul E. Gagnon、Guy Nadeau、Raymond Côté

  DOI：10.1139/v52-071

  日期：1952.8.1

  Monosubstituted cyanoacetic esters, obtained by condensation of 1-bromo-3(s)-phenoxypropanes (s = o-Cl, o-Br, o-I, o-, m-, and p-NO2) or 1-bromo-2(s)-phenoxyethanes (s = o-Cl, o-Br, o-I, and m-NO2) with ethyl cyanoacetate by means of potassium carbonate, were transformed through a Curtius degradation into cyanoacetisocyanates. These compounds by hydrolysis in acid or alkaline medium gave α-amino acids. However

  单取代的氰基乙酸酯，通过 1-bromo-3(s)-phenoxypropanes (s = o-Cl, o-Br, oI, o-, m-, 和 p-NO2) 或 1-bromo-2(s) 缩合获得)-苯氧基乙烷（s = o-Cl、o-Br、oI 和 m- ）与氰乙酸乙酯通过碳酸钾，通过 Curtius 降解转化为氰基乙酰异氰酸酯。这些化合物通过在酸性或碱性介质中水解产生α-氨基酸。然而，相应的羧苄氧基或羧乙氧基氨基腈的水解提供了更好的产率。羧苄氧基氨基腈在盐酸水溶液中比羧甲氧基氨基腈更容易水解。此外，干盐酸对羧苄氧基衍生物的温和作用很容易产生α-氨基酸，而对羧甲氧基衍生物进行类似处理则产生了羧甲氧基氨基酸。
• Bicyclic pyridinones
  申请人：Pfizer Inc.

  公开号：US09067934B2

  公开（公告）日：2015-06-30

  Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

  本文披露了化合物及其医药上可接受的盐，其中化合物的结构符合此处定义的公式I。同时还披露了相应的制药组合物、治疗方法、合成方法和中间体。